Home LiteratureArticle Details
PMID: 10678942 Published · ppublish English Comparative Study Journal Article Research Support, Non-U.S. Gov't

Direct quantitative transcript analysis of the agr regulon of Staphylococcus aureus during human infection in comparison to the expression profile in vitro.

Infection and immunity ·Vol. 68 ·No. 3 ·2000-03-00 ·Pages 1304-11

Goerke C, Campana S, Bayer MG, Döring G, Botzenhart K, Wolz C

Abstract

Bacteria possess a repertoire of distinct regulatory systems promoting survival in disparate environments. Under in vitro conditions it was demonstrated for the human pathogen Staphylococcus aureus that the expression of most virulence factors is coordinated by the global regulator agr. To monitor bacterial gene regulation in the host, we developed a method for direct transcript analysis from clinical specimens. Quantification of specific transcripts was performed by competitive reverse transcription-PCR, and results were normalized against the constitutively expressed gene for gyrase (gyr). Using sputum from cystic fibrosis (CF) patients infected with S. aureus we examined the transcription of the effector molecule RNAIII of agr, of spa (protein A), generally repressed by agr, and of hla (alpha-toxin), generally activated by agr. In the CF lung RNAIII was expressed poorly, indicating an inactive agr in vivo. Despite the low level of RNAIII expression, spa was detectable only in minute amounts and an irregular transcription of hla was observed in all sputum samples. After subculturing of patient strains agr-deficient isolates and isolates with unusual expression profiles, i.e., not consistent with those obtained from prototypic strains, were observed. In conclusion, the agr activity seems to be nonessential in CF, and from the described expression pattern of spa and hla, other regulatory circuits aside from agr are postulated in vivo.

MeSH Terms
Bacterial Proteins/genetics Bacterial Toxins/genetics Chronic Disease Cystic Fibrosis/complications Hemolysin Proteins/genetics Humans Lung Diseases/metabolism RNA, Messenger/analysis Regulon Reverse Transcriptase Polymerase Chain Reaction Sputum/microbiology Staphylococcal Infections/metabolism Staphylococcal Protein A/genetics Staphylococcus aureus/genetics Trans-Activators Transcription Factors/genetics
Chemicals
Agr protein, Staphylococcus aureus Bacterial Proteins Bacterial Toxins Hemolysin Proteins RNA, Messenger Staphylococcal Protein A Trans-Activators Transcription Factors staphylococcal alpha-toxin
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Goerke C
Allgemeine Hygiene und Umwelthygiene, Universität Tübingen, Tübingen, Germany.
Campana S
Bayer M G
Döring G
Botzenhart K
Wolz C
References (34)
34 references, click to expand
  1. Identification of a chromosomal determinant of alpha-toxin production in Staphylococcus aureus.
    Infect Immun. 1980 Oct;30(1):36-42 PMID: 6254884
  2. Typing of Staphylococcus aureus by pulsed-field gel electrophoresis, zymotyping, capsular typing, and phage typing: resolution of clonal relationships.
    J Clin Microbiol. 1993 Feb;31(2):227-32 PMID: 8432807
  3. Virulence of protein A-deficient and alpha-toxin-deficient mutants of Staphylococcus aureus isolated by allele replacement.
    Infect Immun. 1987 Dec;55(12):3103-10 PMID: 3679545
  4. Inactivation of the alpha-haemolysin gene of Staphylococcus aureus 8325-4 by site-directed mutagenesis and studies on the expression of its haemolysins.
    Microb Pathog. 1986 Apr;1(2):125-38 PMID: 3508485
  5. Protein phosphorylation and regulation of adaptive responses in bacteria.
    Microbiol Rev. 1989 Dec;53(4):450-90 PMID: 2556636
  6. The role of the delta-lysin gene (hld) in the regulation of virulence genes by the accessory gene regulator (agr) in Staphylococcus aureus.
    EMBO J. 1990 May;9(5):1391-9 PMID: 2328718
  7. Genetic systems in staphylococci.
    Methods Enzymol. 1991;204:587-636 PMID: 1658572
  8. The accessory gene regulator (agr) controls Staphylococcus aureus virulence in a murine arthritis model.
    Infect Immun. 1993 Sep;61(9):3879-85 PMID: 8359909
  9. Involvement of the accessory gene regulator (agr) in expression of type 5 capsular polysaccharide by Staphylococcus aureus.
    J Gen Microbiol. 1993 Jun;139 Pt 6:1301-6 PMID: 8360622
  10. Synthesis of staphylococcal virulence factors is controlled by a regulatory RNA molecule.
    EMBO J. 1993 Oct;12(10):3967-75 PMID: 7691599
  11. Corneal virulence of Staphylococcus aureus: roles of alpha-toxin and protein A in pathogenesis.
    Infect Immun. 1994 Jun;62(6):2478-82 PMID: 8188373
  12. Diminished virulence of a sar-/agr- mutant of Staphylococcus aureus in the rabbit model of endocarditis.
    J Clin Invest. 1994 Nov;94(5):1815-22 PMID: 7962526
  13. Autocrine regulation of toxin synthesis by Staphylococcus aureus.
    Proc Natl Acad Sci U S A. 1995 Feb 28;92(5):1619-23 PMID: 7533297
  14. Simultaneous identification of bacterial virulence genes by negative selection.
    Science. 1995 Jul 21;269(5222):400-3 PMID: 7618105
  15. The agr P2 operon: an autocatalytic sensory transduction system in Staphylococcus aureus.
    Mol Gen Genet. 1995 Aug 30;248(4):446-58 PMID: 7565609
  16. Cell density control of staphylococcal virulence mediated by an octapeptide pheromone.
    Proc Natl Acad Sci U S A. 1995 Dec 19;92(26):12055-9 PMID: 8618843
  17. Characterization of the sar locus and its interaction with agr in Staphylococcus aureus.
    J Bacteriol. 1996 Jan;178(2):418-23 PMID: 8550461
  18. Transcriptional control of the agr-dependent virulence gene regulator, RNAIII, in Staphylococcus aureus.
    Mol Microbiol. 1996 Sep;21(6):1227-37 PMID: 8898391
  19. Cystic fibrosis.
    Am J Respir Crit Care Med. 1996 Nov;154(5):1229-56 PMID: 8912731
  20. Regulation of protein A synthesis by the sar and agr loci of Staphylococcus aureus.
    Infect Immun. 1997 Jun;65(6):2243-9 PMID: 9169758
  21. Variation in the agr-dependent expression of alpha-toxin and protein A among clinical isolates of Staphylococcus aureus from patients with septicaemia.
    FEMS Microbiol Lett. 1997 Jul 1;152(1):155-61 PMID: 9228782
  22. Regulation of Staphylococcus aureus capsular polysaccharide type 5: CO2 inhibition in vitro and in vivo.
    J Infect Dis. 1997 Aug;176(2):431-8 PMID: 9237709
  23. A site-directed Staphylococcus aureus hemB mutant is a small-colony variant which persists intracellularly.
    J Bacteriol. 1997 Aug;179(15):4706-12 PMID: 9244256
  24. Localization of Staphylococcus aureus in infected airways of patients with cystic fibrosis and in a cell culture model of S. aureus adherence.
    Am J Respir Cell Mol Biol. 1998 Jul;19(1):83-91 PMID: 9651183
  25. Staphylococcus aureus genetic loci impacting growth and survival in multiple infection environments.
    Mol Microbiol. 1998 Oct;30(2):393-404 PMID: 9791183
  26. Staphylococcal coagulase; mode of action and antigenicity.
    J Gen Microbiol. 1952 Feb;6(1-2):95-107 PMID: 14927856
  27. Identification of Staphylococcus aureus virulence genes in a murine model of bacteraemia using signature-tagged mutagenesis.
    Mol Microbiol. 1997 Oct;26(2):399-407 PMID: 9383163
  28. Molecular interactions between two global regulators, sar and agr, in Staphylococcus aureus.
    J Biol Chem. 1998 Jan 30;273(5):2645-52 PMID: 9446568
  29. Persistent infection with small colony variant strains of Staphylococcus aureus in patients with cystic fibrosis.
    J Infect Dis. 1998 Apr;177(4):1023-9 PMID: 9534977
  30. Identification of novel staphylococcal virulence genes by in vivo expression technology.
    Mol Microbiol. 1998 Mar;27(5):967-76 PMID: 9535086
  31. Environmental signals controlling expression of virulence determinants in bacteria.
    J Bacteriol. 1992 Jan;174(1):1-7 PMID: 1729202
  32. Selection of bacterial virulence genes that are specifically induced in host tissues.
    Science. 1993 Jan 29;259(5095):686-8 PMID: 8430319
  33. Phenotypic characterization of xpr, a global regulator of extracellular virulence factors in Staphylococcus aureus.
    Infect Immun. 1993 Mar;61(3):919-25 PMID: 8432612
  34. Antibodies to staphylococcal teichoic acid and alpha toxin in patients with cystic fibrosis.
    Acta Paediatr Scand. 1986 Jan;75(1):139-44 PMID: 3953269
Article Info
Journal
Infection and immunity
Abbr.
Infect Immun
ISSN
0019-9567
Published
2000-03-00
Pages
1304-11
Language
English
Region
United States
NLM ID
0246127
PMCID
PMC97283
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]